In the Ipledge program, what steps are required?

• A. The patient must sign a waiver
• B. Doctor and pharmacist must fill out a list of questions; type in patient id and date of birth; if authorized, you’ll be given a RMA # and a dispense by this date (record both on the prescription and re-scan)
• C. The RMA number is issued automatically without verification
• D. Only the patient ID is required

Answer: (B)

The question is asking about the required steps to dispense isotretinoin under the iPLEDGE program. The process relies on a collaborative verification: the prescriber and the pharmacist complete a set of screening questions and enter the patient’s ID and date of birth to confirm identity and eligibility. If the patient passes and is authorized, an iPLEDGE Risk Management Agreement (RMA) number is issued and a dispense-by date is established. Both the RMA number and the dispense-by date must be recorded on the prescription and re-scanned in the system to prove compliance. This workflow ensures proper enrollment, safety checks (including pregnancy risk management for females of childbearing potential), and timely, traceable dispensing.

The other options don’t fit because there isn’t a waiver to sign, the RMA isn’t issued automatically without verification, and just providing the patient ID alone isn’t sufficient for the required safeguards and documentation.